SUMMARY The resistogram method was applied to 420 isolates of Candida albicans obtained from 30 selected patients undergoing treatment for vulvovaginitis. Of these, 16 patients each harboured a particular strain of C. albicans which persisted in the mouth or intestinal tract or both. In three of these patients, this strain persisted in the genital tract, and, in eight patients, it later recolonised the genital tract. Fourteen patients harboured more than one strain of C. albicans: one failed to respond to treatment and continued to harbour the same strain in the genital tract; in five the original strain later recolonised the genital tract and a second strain remained confined to the mouth or intestinal tract or both; and in three a second strain, present in the intestinal tract, later colonised the genital tract. Each of the male partners of seven patients harboured a strain of C. albicans that was identical to the strain, or to one of the strains, that had been isolated from his female partner.
Introduction
The current prevalence of vaginal infection with Candida albicans has led to increased interest in the epidemiological aspects of this condition. The source of this infection is an intriguing problem, and its elucidation might be helpful in treating the patient. Most patients harbouring C. albicans in the genital tract are also harbouring this fungus in the mouth and anal tract (Hilton and Warnock, 1975) , and Miles et al. suggested that the digestive tract could be the principal source of vaginal infection (Miles et al., 1977) . Furthermore, transmission of C. albicans from the male partner might be contributing to the vaginal infection in certain patients (Rodin and Kolator, 1976; Davidson, 1977) .
The differentiation of isolates of C. albicans has in the past been restricted to the two serological groups of Hasenclever and Mitchell (1961) . In practice, most clinical isolates have been found to belong to one of these groups (Hasenclever and Mitchell, 1963) , and this has limited the usefulness of this method for tracing the spread of C. albicans infection.
Warnock et aL (1979) described a resistogram method for differentiation of strains of C. albicans based on differences in the resistance of strains of C. albicans to a number of selected chemicals used at critical concentrations. Up to 1092 hypothetical strains of C. albicans can be distinguished with this method. The method was tested with isolates from 13 patients undergoing treatment for vaginal infection with C. albicans, and it was found that particular strains were consistently present in individual patients, both in different specimens and on different occasions. Furthermore, some patients harboured more than one strain of C. albicans. This paper presents the findings of an epidemiological investigation of 30 patients treated for vulvovaginal infection with C. albicans. The strains of C. albicans present in the mouth, digestive tract, and genital tract of these patients before and after treatment were characterised by the resistogram method. Isolates of C. albicans obtained from the male partners of seven patients were also studied. (Milne and Warnock, 1979) and were included in this investigation provided that a minimum of six isolates of C. albicans had been obtained and the patient had attended on at least three occasions. The patients were first seen before starting treatment for vulvovaginal infection with C. albicans; 24 of them had also had such an infection diagnosed on at least one previous occasion ( English (1974) . RESISTOGRAM DETERMINATION This was performed according to the methods of Warnock et al. (1979) .
The resistogram of each C. albicans strain is a list of the chemicals to which that strain is resistant. Each chemical is alloted a letter of the alphabet so that if a strain is resistant to chemical B, the letter B is included in the description of that strain. If a strain is resistant to all the chemicals used, its resistogram is given as A B C D E F. If chemicals A and D inhibit a strain, the resistogram of that strain is given as B C E F. If a chemical causes partial inhibition of a strain, this is denoted by the letter bracketed.
If two isolates demonstrate a major difference in resistance to one or more chemicals-for example, A B C D E and B C D E-or minor differences in resistance to two or more chemicals-for example, A B C D E and (A)(B) C D E or (A)(B) C D E and C D E-the isolates are considered to belong to distinct strains.
Results
The findings for the 30 female patients in this investigation are summarised in Table 1: 420 colonies of C. albicans from the cultures of 420 specimens were subcultured for characterisation. In 26 patients the initial course of treatment eliminated the genital tract infection; in 10 of these patients, genital tract recolonisation did not occur. In the other 20 patients, the genital tract remained colonised or became recolonised once treatment had ceased. Thirteen of these 20 patients developed further clinical signs of genital infection and required a second course of treatment. Five of these 13 patients later received a third course of treatment, and one patient required a fourth course of treatment. In all, 16 patients (Patients 1-5 and 11-21) harboured one particular strain of C. albicans throughout the period of investigation, and the other 14 patients (Patients 6-10 and 22-30) harboured two distinct strains.
Five of the 10 patients (Patients 1-5) in whom genital colonisation did not recur harboured a particular strain of C. albicans in both the digestive tract and the genital tract. In three of the five other patients in whom genital colonisation did not recur (Patients 6, 7, and 8), two strains of C. albicans were isolated before treatment. The strain that was isolated from the anus and genital tract of these three patients before treatment did not reappear after treatment. In Patients 9 and 10, a second strain appeared in the digestive tract after treatment. [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] Patient 26 received four courses of treatment and on each occasion it was the same strain that was isolated from both the genital tract and the digestive tract. A second strain did appear in the mouth of this patient; this strain had earlier been isolated from the mouth of the male partner of this particular patient ( Table 2) .
The male partners of seven female patients were studied; 12 isolates of C. albicans were obtained for characterisation (Table 2) . Each male patient was harbouring a strain of C. albicans that was identical to the strain, or one of the strains, that had been isolated from his female partner. (21) M (12) The findings of our previous investigation suggested that particular strains of C.
albicans were present in individual patients. One of the patients studied harboured more than one strain of C. albicans, and this raised the problem of the number of colonies from each clinical specimen that needed to be tested to detect all the strains that might be present. In its present form, the resistogram method permits 15 isolates to be tested on each occasion. In this investigation, the need to test isolates from all the specimens obtained from a particular patient on the same occasion restricted the number of colonies that could be sampled from each clinical specimen. It cannot, therefore, be assumed that if a strain was not detected in a particular specimen on a particular occasion that strain was not present in that specimen. It should be emphasised that other methods of strain differentiation share this fundamental problem.
There have been no reports that C. albicans can become resistant to the antifungal preparations used to treat vaginal candidosis. It has been assumed, therefore, that the failure of some patients to respond to treatment, and the need of others for prolonged or repeated courses of treatment, is due (in part at least) to reinfection from their partner or from their own intestinal tract. Furthermore, the recurrence of genital infection in some patients may possibly be a consequence of incomplete eradication of the initial vaginal infection.
The presence of C. albicans in the genital tract is often associated with its presence in the digestive tract (Hilton and Warnock, 1975; Miles et al., 1977) . Our findings confirm this association and suggest that most, if not all, patients with genital infection are also harbouring the same strain of C. albicans in the digestive tract. The fact that most of our patients harboured the same strain of C. albicans in the mouth and intestinal tract suggests that the mouth might be contributing to continuing intestinal colonisation.
The findings suggest that, in patients with profuse vaginal discharge, contamination from the genital tract could be contributing to anal colonisation. Of the seven patients harbouring two distinct strains of C. albicans before treatment, five were harbouring one strain in both the anus and the genital tract, and the second strain was present in the mouth or intestinal tract or both. In three (Patients 6, 7, and 8) of these five patients, the strain present in the anus and genital tract before treatment did not reappear after treatment. In the other patients (Patients 22 and 25), the strain that was isolated from the anus and genital tract before treatment later returned; this strain was not isolated from the mouth or intestinal tract. In another patient (Patient 24), the strain that was isolated from the genital tract before treatment was later isolated from the anus and genital tract. It has sometimes been suggested (Rodin and Kolator, 1976; Davidson, 1977) that C. albicans is transmitted to or from the male partner. Our findings support this suggestion; identical strains of C. albicans were isolated from the genitalia of three pairs of patients, and in the other four pairs of patients studied both partners harboured the same strain in the mouth or digestive tract. Most of our female patients admitted orogenital contact, which suggests that transmission of C. albicans from the mouth might be contributing to the genital colonisation in some patients.
This investigation has shown that most patients with vulvovaginal candidosis harbour the same strain of C. albicans in the mouth, intestinal tract, anus, and genital tract and that the male partner often harbours the same strain. Our findings suggest that the failure of patients to respond to treatment is often due to incomplete eradication of the initial infection. In other patients, recurrent vaginal infection is due, in part at least, to reinfection from the intestinal tract or from the male partner. 
